|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1999-2-5
|
|
pubmed:abstractText |
To assess the pharmacokinetics of paclitaxel for recurrent Wilms' tumor in an anephric pediatric patient receiving hemodialysis. Methods: Paclitaxel was administered at a dose of 250 mg/m2 and 350 mg/m2 by 24-h continuous intravenous (IV) infusion as two consecutive courses, respectively, separated by approximately 3 weeks. Paclitaxel plasma concentrations were measured by high-performance liquid chromatography (HPLC).
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0344-5704
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
43
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
92-6
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:9923547-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:9923547-Area Under Curve,
pubmed-meshheading:9923547-Child,
pubmed-meshheading:9923547-Female,
pubmed-meshheading:9923547-Humans,
pubmed-meshheading:9923547-Infusions, Intravenous,
pubmed-meshheading:9923547-Kidney Neoplasms,
pubmed-meshheading:9923547-Neoplasm Recurrence, Local,
pubmed-meshheading:9923547-Nephrectomy,
pubmed-meshheading:9923547-Paclitaxel,
pubmed-meshheading:9923547-Renal Dialysis,
pubmed-meshheading:9923547-Wilms Tumor
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Pharmacokinetics of paclitaxel in an anephric patient.
|
|
pubmed:affiliation |
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Case Reports,
Research Support, Non-U.S. Gov't
|
